Cryoport Inc CYRX.OQ CYRX.O is expected to show a rise in quarterly revenue when it reports results on March 4 for the period ending December 31 2024
The Brentwood Tennessee-based company is expected to report a 2.2% increase in revenue to $58.548 million from $57.26 million a year ago, according to the mean estimate from 9 analysts, based on LSEG data.
‚ÄčLSEG's mean analyst estimate for Cryoport Inc is for a loss of 29 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč
Wall Street's median 12-month price target for Cryoport Inc is $11.00‚Äč, above‚Äč its last closing price of $5.65. ‚Äč‚Äč‚Äč
Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč
QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-0.30
-0.29
-0.02
Beat
93.2
Jun. 30 2024
-0.39
-0.39
-0.29
Beat
26.2
Mar. 31 2024
-0.35
-0.35
-0.43
Missed
-23.6‚Äč
Dec. 31 2023
-0.30
-0.29
-1.31
Missed
-347.6
‚Äč‚ÄčSep. 30 2023
-0.32
-0.30
-0.31
Missed
-1.6
Jun. 30 2023
-0.26
-0.24
-0.42
Missed
-77.6‚Äč
Mar. 31 2023
-0.21
-0.19
-0.16
Beat
14.8
Dec. 31 2022
-0.20
-0.19
-0.24
Missed
-24.1
This summary was machine generated February 28 at 21:31 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)